Search clinical trials for: IBI188, Rituximab
Total 3195 results
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Puerto Rico, South Africa
-
BiogenCompletedNon-Hodgkin's LymphomaSweden, Czech Republic, France, Russian Federation, Turkey, United Kingdom, Germany, Lithuania, Romania, United States, Austria
-
Rambam Health Care CampusTechnion, Israel Institute of TechnologyUnknown
-
University of Alabama at BirminghamCompletedPurpura, Thrombocytopenic, IdiopathicUnited States
-
Charite University, Berlin, GermanyHoffmann-La RocheUnknownAnkylosing SpondylitisGermany
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Lymphoma Study AssociationAmgenTerminatedDiffuse Large Cell LymphomaFrance, Belgium, Switzerland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada
-
Dong-A University HospitalCompleted
-
University of California, San FranciscoCompletedLymphoma | Brain and Central Nervous System Tumors
-
Assistance Publique - Hôpitaux de ParisCompletedThrombotic Thrombocytopenic PurpuraFrance
-
Neufeld, Ellis J, MD, PhDGenentech, Inc.; Biogen; Glaser Pediatric Research Network; Terrana ITP Research...CompletedImmune Thrombocytopenic Purpura (ITP) | Idiopathic Thrombocytopenic Purpura (ITP)United States
-
National Pediatric Neuroinflammation Organization...Genentech, Inc.CompletedAtaxia | Myoclonus | Opsoclonus-myoclonus Syndrome | OpsoclonusUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisUnknown
-
BiogenTerminated
-
National Institute of Allergy and Infectious Diseases...Clinical Trials in Organ Transplantation; Cooperative Clinical Trials in Pediatric...CompletedKidney Transplant | Kidney Transplant Recipient | Graft Function/Survival | de Novo HLA Antibodies DevelopmentUnited States
-
Stanford UniversityCompleted
-
University Hospital ErlangenCompletedLymphoma | LeukemiaGermany, Switzerland
-
CelltrionCompletedRheumatoid ArthritisKorea, Republic of
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)TerminatedLymphomaUnited States
-
Swiss Group for Clinical Cancer ResearchCompleted
-
BiogenCompletedLow-Grade or Follicular B-Cell Non-Hodgkin's LymphomaUnited States, Canada
-
Sichuan UniversityInnovent Biologics (Suzhou) Co. Ltd.Completed
-
Seoul National University HospitalGyeongsang National University Hospital; Hallym University Medical Center; Kyunghee...TerminatedCD20-positive Non-Hodgkin LymphomaKorea, Republic of
-
Papworth Hospital NHS Foundation TrustCompletedMyocardial Infarction | Inflammation | Ischemic Heart DiseaseUnited Kingdom
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.Completed
-
Swiss Group for Clinical Cancer ResearchCompletedLymphomaSwitzerland, South Africa, Italy, Brazil, North Macedonia, Serbia, Slovakia
-
Stephen Howell, M.D.Genentech, Inc.UnknownProstate CancerUnited States
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Chronic Lymphocytic LeukemiaUnited States
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Follicular Lymphoma or Mantle Cell LymphomaKorea, Republic of
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Marginal Zone B-cell LymphomaKorea, Republic of
-
Andres J. M. FerreriCompletedOcular Adnexal Mucosa-Associated Lymphoid Tissue LymphomaItaly
-
Lixia ShengNot yet recruitingOR Regimen Refractory Marginal Zone Lymphoma
-
Beijing Friendship HospitalRecruitingChronic Active Epstein-Barr Virus Infection | Secondary Hemophagocytic LymphohistiocytosisChina
-
New York Medical CollegeRecruitingImmune Thrombocytopenic PurpuraUnited States
-
Cogent Biosciences, Inc.Terminated
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI)CompletedThrombotic Thrombocytopenic PurpuraUnited States
-
Cogent Biosciences, Inc.Completed
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
International Extranodal Lymphoma Study Group (IELSG)Withdrawn
-
Ostfold Hospital TrustOslo University Hospital; South-Eastern Regional Health AuthorityCompleted
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Diffuse Large B Cell LymphomaKorea, Republic of
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Buhai WangInnovent Biologics (Suzhou) Co. Ltd.UnknownCervical Cancer | Uterine Cervical Neoplasms | Cervix Cancer | Cervical NeoplasmsChina
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI); AbbVieWithdrawnRichter Syndrome | Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma | Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma | Recurrent Transformed Chronic Lymphocytic Leukemia | Refractory Transformed Chronic Lymphocytic LeukemiaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Centre Hospitalier Universitaire de NiceNot yet recruiting
-
Mayo ClinicGenentech, Inc.CompletedFibrillary GlomerulonephritisUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Brigham and Women's HospitalCompletedB-cell Lymphoma | Indolent B-cell LymphomaUnited States